Catalyst Wire Dossier Catalyst Wire Dossier

SCMC-Lys Salt

SCMC-Lys Salt · Dompé Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCMC-Lys Salt, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup [Phase 1]

See pricing